BIOSAFE Labs and Glycemion to Provide Free Diabetes Risk Assessment Kits to U.S. School Children

LAKE FOREST, Ill., Feb. 5 /PRNewswire/ -- BIOSAFE Laboratories, Inc., the developer of the BIOSAFE Diabetes Risk Assessment, and Glycemion, the United States distributor, have announced the availability of a limited number of test kits for use in schools to help identify diabetic and pre-diabetic children and adolescents. The BIOSAFE Diabetes Risk Assessment is a two-part process comprised of an immediate fasting glucose reading and a mail-in laboratory analysis for hemoglobin A1c, a blood glucose marker for the previous ninety-day period. Samples for both tests can be either professionally collected or self-collected through the use of a simple finger-nick collection kit. Taken in combination, these two results become a reliable indicator of diabetes or a pre-diabetes condition.

Type 2 diabetes (non-insulin dependent diabetes) affects more than 20 million Americans and is the most common form of the disease. However, because diabetes exhibits few if any symptoms until its advanced stages, millions more are in eminent danger of developing the disease and are unaware of it. When blood glucose (sugar) levels are higher than normal, but not yet high enough to be classified as diabetes, a condition known as pre-diabetes exists. If discovered early, a person with pre-diabetes can avoid the devastating complications of diabetes through education, diet, exercise, and appropriately prescribed medications.

"Diabetes is a debilitating, crippling, and life-shortening disease whose most serious complications like blindness, heart disease and kidney failure can often be prevented with early detection. Current trends show that the incidence of diabetes is increasing among children and adolescents. For this reason we are pleased to make the BIOSAFE Diabetes Risk Assessment available to school age children to assist in the early identification of diabetes and pre-diabetes," said Jack Maggiore, PhD, president of BIOSAFE Laboratories, Inc. "Despite decades of medical advances for the treatment of diabetes, millions of people remain unknowingly undiagnosed and at risk for the disease. By working in partnership with others who provide medicine and products to diabetic and pre-diabetic populations, our mission is to provide this quick and convenient kit to school programs, so that those who are identified as being in a pre-diabetic state can work with their physicians, school nurses and diabetes educators to implement dietary and healthy lifestyle changes to avoid the catastrophic complications of diabetes."

Schools interested in learning more about this program may contact Danielle Warner at dwarner@ebiosafe.com or Dana Green at dgreen@ebiosafe.com. Located in Chicago, Illinois, BIOSAFE Laboratories, Inc. develops, manufactures, and processes health monitoring and testing products for the consumer, physician, health screening, occupational health, pharmaceutical, disease-management, and medical research markets.

Glycemion, Inc. is an independent distributor of the BIOSAFE Diabetes Risk Assessment and other rapid results products and marketing services.

For more information about BIOSAFE or Glycemion, Inc., contact Dana Green at 847-234-8111, ext.122 fax 847-234-8222, email dgreen@ebiosafe.com or visit http://www.ebiosafe.com.

CONTACT: Dana Green of BIOSAFE Laboratories, Inc., +1-847-234-8111, ext.
122, fax, +1-847-234-8222, dgreen@ebiosafe.com

Web site: http://www.ebiosafe.com//